Randomized Controlled Trial of a Supportive Care Digital Application (THRIVE-CAR-T) for Patients Receiving CAR-T Cell Therapy
Sponsor: Patrick C. Johnson, MD
Trial Details
| Condition | CAR T-Cell Therapy |
| Intervention | THRIVE-CAR-T |
| Phase | NA |
| Status | Recruiting |
| Participants | 100 |
| Est. Completion | 1 Nov 2026 |
| Last Updated | 1 Apr 2026 |
Primary Outcome
Feasibility
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: 1. Age 18 years or older 2. Ability to understand English 3. Diagnosis of a hematologic malignancy 4. Receiving autologous CAR-T at MGH with an FDA approved cellular therapy product Exclusion Criteria: 1. Impaired cognition or uncontrolled mental illness that prohibits the ability to provide informed consent based on the oncology clinician assessment 2. Already participating in another supportive care clinical trial
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service